2012
Genetically modified lactococcus lactis for delivery of human interleukin-10 to dendritic cells
Publication
Publication
Interleukin-10 (IL-10) plays an indispensable role in mucosal tolerance by programming dendritic cells (DCs) to induce suppressor Th-cells. We have tested the modulating effect of L. lactis secreting human IL-10 (L.lacti s IL-10) on DC function in vitro. Monocyte-derived DC incubated with L.lacti s IL-10 induced effector Th-cells that markedly suppressed the proliferation of allogenic Th-cells as compared to L. lactis. This suppressive effect was only seen when DC showed increased CD83 and CD86 expression. Furthermore, enhanced production of IL-10 was measured in both L.lacti s IL-10 -derived DC and Th-cells compared to L. lactis-derived DC and Th-cells. Neutralizing IL-10 during DC-Th-cell interaction and coculturing L.lacti s IL-10 -derived suppressor Th-cells with allogenic Th-cells in a transwell system prevented the induction of suppressor Th-cells. Only 130pg/mL of bacterial-derived IL-10 and 40 times more exogenously added recombinant human IL-10 were needed during DC priming for the generation of suppressor Th-cells. The spatially restricted delivery of IL-10 by food-grade bacteria is a promising strategy to induce suppressor Th-cells in vivo and to treat inflammatory diseases.
Additional Metadata | |
---|---|
doi.org/10.1155/2012/639291, hdl.handle.net/1765/35030 | |
Gastroenterology Research and Practice | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Braat, H., Huibregtse, I., Zaat, S., Kapsenberg, M., Sartori da Silva, M. A., Peppelenbosch, M., & van Deventer, S. (2012). Genetically modified lactococcus lactis for delivery of human interleukin-10 to dendritic cells. Gastroenterology Research and Practice. doi:10.1155/2012/639291 |